Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps
出版年份 2017 全文链接
标题
Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps
作者
关键词
-
出版物
JOURNAL OF ANTIBIOTICS
Volume 70, Issue 12, Pages 1087-1096
出版商
Springer Nature
发表日期
2017-11-01
DOI
10.1038/ja.2017.124
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Global Antimicrobial Conservation Fund for Low- and Middle-Income Countries
- (2016) Marc Mendelson et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach
- (2016) John H Rex et al. LANCET INFECTIOUS DISEASES
- Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis
- (2016) Ruth Kelly et al. LANCET INFECTIOUS DISEASES
- Accelerating global innovation to address antibacterial resistance: introducing CARB-X
- (2016) Kevin Outterson et al. NATURE REVIEWS DRUG DISCOVERY
- A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility
- (2016) David M. Brogan et al. Globalization and Health
- Strategies for achieving global collective action on antimicrobial resistance
- (2015) Steven J Hoffman et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Repairing The Broken Market For Antibiotic Innovation
- (2015) Kevin Outterson et al. HEALTH AFFAIRS
- A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics
- (2015) Matthew J Renwick et al. JOURNAL OF ANTIBIOTICS
- The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance
- (2015) T. Kostyanev et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Innovative Medicines Initiative and antibiotic resistance
- (2015) Tomislav Kostyanev et al. LANCET INFECTIOUS DISEASES
- Antibiotics in the clinical pipeline in 2013
- (2013) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- A comprehensive regulatory framework to address the unmet need for new antibacterial treatments
- (2013) John H Rex et al. LANCET INFECTIOUS DISEASES
- Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model
- (2013) David M Brogan et al. Globalization and Health
- Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement
- (2008) Ian Chopra et al. LANCET INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started